NCT06971640 Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition
| NCT ID | NCT06971640 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | ADHD - Attention Deficit Disorder With Hyperactivity |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2025-05-28 |
| Primary Completion | 2029-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2025-05-28 with a primary completion date of 2029-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to better understand sleep and circadian functioning in children with ADHD using home-based measures, parent report, and a lab based melatonin assessment. Investigators will also examine how sleep relates to psychiatric health and cognition among children with ADHD. The investigator for this study is Dr. Jessica Lunsford-Avery from the Department of Psychiatry.
Eligibility Criteria
Inclusion Criteria: 1. Child ages 6-9 2. Meet criteria for a primary psychiatric diagnosis of DSM-5 ADHD, any presentation 3. Intellectual functioning \>80 4. Healthy (i.e., no major medical problems) 5. If applicable, willingness to suspend use of melatonin during the study period Exclusion Criteria: 1. Meet DSM-5 criteria for psychosis, bipolar, or autism spectrum disorders 2. Diagnosis of occult sleep disorders, including sleep apnea or restless leg syndrome 3. Medication for sleep other than melatonin 4. Plans to initiate stimulant medication during the study period
Contact & Investigator
Jessica Lunsford-Avery, Ph.D.
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT06971640 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 9 Years, studying ADHD - Attention Deficit Disorder With Hyperactivity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06971640 currently recruiting?
Yes, NCT06971640 is actively recruiting participants. Contact the research team at matthew.gibson646@duke.edu for enrollment information.
Where is the NCT06971640 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT06971640 clinical trial?
NCT06971640 is sponsored by Duke University. The principal investigator is Jessica Lunsford-Avery, Ph.D. at Duke University. The trial plans to enroll 250 participants.